Investigational Drug Steering Committee Roster
The Investigational Drug Steering Committee (IDSC) collaborates with the NCI in the design and prioritization of early phase drug development trials carried out within the Experimental Therapeutics Clinical Trials Network (ETCTN) with agents for which NCI’s Cancer Therapy and Evaluation Program (CTEP) holds an Investigational New Drug (IND) application. The IDSC's membership comprises Principal Investigators of CTEP’s Phase 1 U01 and Phase 2 early drug development grants, NCTN group representatives, subject matter experts in trial design, clinical imaging, radiation therapy, pharmacokinetics/pharmacodynamics, cancer omics, health-related quality of life, and biostatistics, as well as patient advocates and NCI staff.
Co-chairs
Patricia M. LoRusso, D.O.
Yale University
New Haven, CT
Geoffrey I. Shapiro M.D., Ph.D.
Dana-Farber Cancer Institute
Boston, MA
Members
Carol Aghajanian, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY
Susanne Arnold, M.D.
University of Kentucky
Lexington, KY
Sharyn D. Baker, Pharm.D., Ph.D.
The Ohio State University Comprehensive Cancer Center
Columbus, OH
Philippe Bedard, M.D., FRCPC
University of Toronto Princess Margaret Cancer Centre
Toronto, ON, Canada
Chandra Belani, M.D.
Pennsylvania State University Cancer Institute
Hershey, PA
Jordan Berlin, M.D., Ph.D.
Vanderbilt University Ingram Cancer Center
Nashville, TN
Jan Beumer, Pharm.D., Ph.D.
University of Pittsburgh Cancer Institute
Pittsburgh, PA
Michael Carducci, M.D.
Johns Hopkins University
Baltimore, MD
William Carson, M.D.
The Ohio State University Medical Center
Columbus, OH
Alice Chen, M.D.
National Cancer Institute
Bethesda, MD
A. Dimitrios Colevas, M.D.
Stanford University
Stanford, CA
Brian A. Costello, M.D.
Mayo Clinic
Rochester, MN
Kevin Courtney, M.D., Ph.D.
University of Texas Southwestern Medical Center
Dallas, TX
Alexey V. Danilov, M.D., Ph.D.
City of Hope
Duarte, CA
Elizabeth Claire Dees, M.D., M.Sc., Sc.M.
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, NC
Adam Dicker, M.D., Ph.D., FASTRO
Thomas Jefferson University
Philadelphia, PA
Keith T. Flaherty, M.D.
Massachusetts General Hospital
Boston, MA
Elizabeth Fox, M.D., M.S.
St. Jude Children's Research Hospital
Memphis, TN
David R. Gandara, M.D.
University of California Davis Comprehensive Cancer Center
Sacramento, CA
Ignacio Garrido-Laguna, M.D., Ph.D.
University of Utah Huntsman Cancer Institute
Salt Lake City, UT
Ryan Gentzler, M.D.
University of Virginia
Charlottesville, VA
Ivana Gojo, M.D.
Johns Hopkins University
Baltimore, MD
Steven Grant, M.D.
Virginia Commonwealth University
Richmond, VA
Salma Jabbour, M.D.
Rutgers Cancer Institute of New Jersey
New Brunswick, NJ
V. Suzanne Klimberg, M.D., Ph.D.
University of Texas Medical Branch at Galveston
Galveston, TX
Donald W. Kufe, M.D.
Dana-Farber Cancer Institute
Boston, MA
Jeffrey Lancet, M.D.
University of South Florida H. Lee Moffitt Cancer Center
Tampa, FL
Primo Lara, M.D.
University of California Davis Comprehensive Cancer Center
Sacramento, CA
Heinz-Josef Lenz, M.D.
University of Southern California Norris Comprehensive Cancer Center
Los Angeles, CA
Glenn Liu, M.D.
University of Wisconsin Comprehensive Cancer Center
Madison, WI
Jason Luke, M.D., FACP
University of Pittsburgh Hillman Cancer Center
Pittsburgh, PA
Devalingam Mahalingam, M.B. B.CH. B.A.O Ph.D.
Northwestern University Feinberg School of Medicine
Chicago, IL
Funda Meric-Bernstam, M.D.
University of Texas MD Anderson Cancer Center
Houston, TX
Wells Messersmith, M.D., Ph.D.
University of Colorado
Aurora, CO
Kathleen Moore, M.D.
University of Oklahoma Stephenson Cancer Center
Oklahoma City, OK
Edward Newman, Ph.D.
City of Hope Beckman Research Institute
Duarte, CA
Amit Oza, M.D., M.B.B.S., FRCPC
University of Toronto Princess Margaret Cancer Centre
Toronto, ON, Canada
John Perentesis, M.D., FAAP
Cincinnati Children's Hospital
Cincinnati, OH
Gina R. Petroni, Ph.D.
University of Virginia
Charlottesville, VA
Jimmy Ruiz, M.D.
Wake Forest University School of Medicine
Winston-Salem, NC
Gary K. Schwartz, M.D.
Case Western Reserve University
Cleveland, OH
Lesley Seymour, M.D., FRCPC
Queen's University
Kingston, ON, Canada
Yu Shyr, Ph.D.
Vanderbilt University Ingram Cancer Center
Nashville, TN
Lillian L. Siu, M.D.
University of Toronto Princess Margaret Cancer Centre
Toronto, ON, Canada
Patricia Spears
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, NC
Naoko Takebe, M.D., Ph.D.
University of Oklahoma Stephenson Cancer Center
Oklahoma City, OK
Richard J. Vetter, Ph.D.
Mayo Clinic
Rochester, MN
Liza C. Villaruz, M.D.
University of Pittsburgh Hillman Cancer Center
Pittsburgh, PA
Patrick Y. Wen, M.D.
Dana-Farber Cancer Institute
Boston, MA
James Yao, M.D.
University of Texas MD Anderson Cancer Center
Houston, TX
NCI CCCT Program Director
Steven Reeves, Ph.D.
steven.reeves@nih.gov